Phylogeny, in situ hybridization service Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on April 16, 2008, 10.1073/pnas.0802915105
PNAS | April 22, 2008 | vol. 105 | no. 16 | E18


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Fornai, F.
Right arrow Articles by Ruggieri, S.
PubMed
Right arrow Articles by Fornai, F.
Right arrow Articles by Ruggieri, S.
Related Content
Right arrow Letters
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents spacer gif

LETTERS
Reply to Bedlack et al.: A small pilot study calls for large clinical trials to evaluate the effects of lithium before prescribing the drug for amyotrophic lateral sclerosis

Francesco Fornai*,{dagger},{ddagger}, Gabriele Siciliano§, Maria Laura Manca§, Luigi Murri§, Antonio Paparelli*, and Stefano Ruggieri{ddagger}

*Department of Human Morphology and Applied Biology and §Department of Neuroscience, Clinical Neurology, University of Pisa, 56100 Pisa, Italy; and {dagger}Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, 86077 Pozzilli (IS), Italy

In response to the letter from Bedlack et al. (1), our small clinical study (2) represents a preliminary screening for potential neuroprotective effects of lithium in ALS, in line with the need for small studies to select new drugs to be tested in large clinical trials (3). This pilot study was based at Istituto Neurologico Mediterraneo, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed in Pozzilli (IS), Italy (protocol deposited on June 14, 2005; registered by the Trials Office on June 21, 2005; approved by the Ethical Committee on July 26, 2005). At the time of publication, we were not aware of the potential to register such studies internationally, a procedure we fully endorse and are using for the multicenter follow-up.

Forty-four . . . [Full Text of this Article]

{ddagger}To whom correspondence may be addressed. E-mail: f.fornai@med.unipi.it


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?